Abiopharma

Form 8.3

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of Director

Innovative Industrial Properties Declares Second Quarter 2026 Dividends

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

Peabody Announces New Surety Arrangements in the U.S. and Australia

Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026

Bandwidth Inc. Announces Proposed Private Offering of $275 Million of Convertible Senior Notes

PGIM Announces Strategic Enhancements to Equity ETF Platform

Genco Shipping & Trading Limited Urges Shareholders to Vote “FOR” its Highly Qualified Directors at June 18th Annual Meeting

Castellum Joint Venture Wins Position on $250 Million U.S. Navy Logistics IT Multiple Award Contract